视频福利在线Ia黄色大片I91少妇精拍在线播放I最新国产中文字幕I五月天色站I天天操福利视频I欧美在线观看禁18I婷婷 中文字幕I青草视频在线看I色资源中文字幕I日韩美视频I成人av在线亚洲

Voice-controlled CRISPR / Cas 9 enhanced sonodynamic therapy for hepatocellular carcinoma is a novel strategy using acoustic control of CRISPR / Cas 9 gene editing system to enhance the killing effect of hepatocellular liver cancer (sonodynamic therapy, HCC) by knocking out antioxidant gene NFE2L2 in tumor cells. Acodyndynamic therapy is a non-invasive therapy that uses the combination of ultrasound and drugs to produce harmful reactive oxygen species (reactive oxygen species, ROS) at the tumor site to kill tumor cells. CRISPR / Cas 9 is a technique that enables precise gene editing and can be used to knockout or repair specific genes. Voice-controlled CRISPR / Cas 9 enhanced sonotherapy for hepatocellular carcinoma can use ultrasound stimulation to realize the release and transfection of CRISPR / Cas 9 system at the tumor site, thus reducing the antioxidant capacity of tumor cells and enhancing the effect of sonodynamic therapy.